期刊
SENSORS
卷 17, 期 7, 页码 -出版社
MDPI AG
DOI: 10.3390/s17071495
关键词
Digital Microfluidics; nucleic acid amplification; point-of-care diagnostics
资金
- FEDER funds through the COMPETE Program [POCI-01-0145-FEDER-007728]
- National Funds through FCT-Portuguese Foundation for Science and Technology [UID/CTM/50025/2013, UID/Multi/04378/2013]
- Water JPI Proj TRACE [281715]
- [SFRH/BPD/124311/2016]
- Fundação para a Ciência e a Tecnologia [SFRH/BPD/124311/2016] Funding Source: FCT
Digital Microfluidics (DMF) has emerged as a disruptive methodology for the control and manipulation of low volume droplets. In DMF, each droplet acts as a single reactor, which allows for extensive multiparallelization of biological and chemical reactions at a much smaller scale. DMF devices open entirely new and promising pathways for multiplex analysis and reaction occurring in a miniaturized format, thus allowing for healthcare decentralization from major laboratories to point-of-care with accurate, robust and inexpensive molecular diagnostics. Here, we shall focus on DMF platforms specifically designed for nucleic acid amplification, which is key for molecular diagnostics of several diseases and conditions, from pathogen identification to cancer mutations detection. Particular attention will be given to the device architecture, materials and nucleic acid amplification applications in validated settings.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据